Reduced indinavir exposure during pregnancy

AIM: To describe the pharmacokinetics and safety of indinavir boosted with ritonavir (IDV/r) during the second and third trimesters of pregnancy and in the post-partum period. METHODS: IMPAACT P1026s is an on-going, prospective, non-blinded study of antiretroviral pharmacokinetics (PK) in HIV-infect...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cressey, Tim R, Best, Brookie M, Achalapong, Jullapong, Stek, Alice, Wang, Jiajia, Chotivanich, Nantasak, Yuthavisuthi, Prapap, Suriyachai, Pornnapa, Prommas, Sinart, Shapiro, David E, Watts, D Heather, Smith, Elizabeth, Capparelli, Edmund, Kreitchmann, Regis, Mirochnick, Mark
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2013
Teme:
Drugs in Pregnancy and Lactation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769674/
https://ncbi.nlm.nih.gov/pubmed/23305215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12078
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items